BIOVECTRA is honored with 2025 CDMO Leadership Award for biologics
BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex ...
BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex ...
A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a ...
Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic ...
Research by UMass Chan Medical School scientists Sharon Cantor, PhD, and Jenna M. Whalen, PhD, poses a new explanation for ...
A decade after scientists in The Picower Institute for Learning and Memory at MIT first began testing whether sensory stimulation ...
A team from University Hospitals Seidman Cancer Center is launching the nation's first-ever clinical trials evaluating the cholesterol drug fenofibrate (Triglide, Fibricor, ...
LabGenius Therapeutics (“LabGenius”), a drug discovery company pioneering the use of machine learning and high-throughput experimentation to optimise complex therapeutic antibodies, ...
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called ...
A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its subtypes, offering new ...
Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking system ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net